Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.74+0.01 (+0.07%)
Close on Nov 13, 2026Market cap $12.30BP/E 26.9Yield 0.58%
Dr Reddys Laboratories operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2026 it was 15.0%, against 22.1% the year before. The highest annual figure on record is 24.3% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | 15.0% | −7.0 |
| FY2025 | Mar 31, 2025 | 22.1% | −2.2 |
| FY2024 | Mar 31, 2024 | 24.3% | +1.0 |
| FY2023 | Mar 31, 2023 | 23.2% | +9.5 |
| FY2022 | Mar 31, 2022 | 13.7% | +1.0 |
| FY2021 | Mar 31, 2021 | 12.8% | +3.6 |
| FY2020 | Mar 31, 2020 | 9.2% | −4.4 |
| FY2019 | Mar 31, 2019 | 13.6% | +5.2 |
| FY2018 | Mar 31, 2018 | 8.4% | −1.2 |
| FY2017 | Mar 31, 2017 | 9.6% | −9.6 |
| FY2016 | Mar 31, 2016 | 19.1% | – |
See a number that looks wrong?